Western blot analysis of extracts from HepG2 tissue using Phospho-PDCD4 (Ser67) antibody.The lane on the right is treated with the antigen-specific peptide.
Western blot analysis of extracts from HepG2 tissue using Phospho-PDCD4 (Ser67) antibody.The lane on the right is treated with the antigen-specific peptide.
Phospho-PDCD4 (Ser67) Antibody
CSB-PA047784
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetPDCD4
Overview
- SupplierCusabio
- Product NamePhospho-PDCD4 (Ser67) Antibody
- Delivery Days Customer20
- ApplicationsWestern Blot, ELISA
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID27250
- Target namePDCD4
- Target descriptionprogrammed cell death 4
- Target synonymsH731; neoplastic transformation inhibitor protein; nuclear antigen H731; programmed cell death 4 (neoplastic transformation inhibitor); programmed cell death protein 4; protein 197/15a
- HostRabbit
- IsotypeIgG
- Protein IDQ53EL6
- Protein NameProgrammed cell death protein 4
- Scientific DescriptionInhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA Kakade D, Islam N, Maeda N, Adegoke OA (2014)BMC Cell Biol 15, 2 . Dorrello NV, et al. (2006)Science 314, 467-71. Palamarchuk A, et al. (2005)Cancer Res 65, 11282-6.
- ReactivityHuman
- Storage Instruction-20°C or -80°C
- UNSPSC12352203